Medtronic Receives Hold Rating from Wolfe Research

Wolfe Research analyst Michael Polark reiterated a Hold rating on Medtronic, citing the company's latest earnings release for the quarter ending July 25, which reported a quarterly revenue of $8.58 billion and a net profit of $1.04 billion. Polark has a 4-star rating and a 51.81% success rate, according to TipRanks.

Medtronic plc (MDT) reported robust financial results for its first quarter (Q1) of fiscal year 2026 (FY26), ending July 25, 2025. The company reported revenue of $8.578 billion, a 8.4% increase as reported and 4.8% organic growth, compared to the same period last year [1]. The adjusted revenue was $8.539 billion, with organic revenue growth of 4.8% [1].

Key highlights include:
- Cardiac Ablation Solutions revenue increased nearly 50%, driven by a 72% increase in the U.S. market, largely due to the strength of pulsed field ablation (PFA) products [1].
- The U.S. Centers for Medicare & Medicaid Services (CMS) proposed a National Coverage Determination (NCD) for the Symplicity Spyral system for hypertension, with a final NCD expected by October 8, 2025 [1].
- Medtronic received CE Mark approval for LigaSure™ RAS vessel-sealing technology on the Hugo™ robotic-assisted surgery (RAS) system [1].

Medtronic's Q1 GAAP operating profit and operating margin were $1.445 billion and 16.8%, respectively, up 13% and 70 basis points year-over-year [1]. Non-GAAP operating profit and operating margin were $2.016 billion and 23.6%, respectively, up 3% and down 80 basis points [1].

The company raised its FY26 EPS guidance to the range of $5.60 to $5.66 per share, from the prior range of $5.50 to $5.60, and expects FY26 organic revenue growth of approximately 5% [1]. This increase is attributed to unexpectedly strong Q1 results and a lessened impact of tariffs.

Wolfe Research analyst Michael Polark reiterated a Hold rating on Medtronic, citing the company's latest earnings release [2]. Polark has a 4-star rating and a 51.81% success rate, according to TipRanks [2].

References:
[1] https://www.todaysmedicaldevelopments.com/news/medtronic-reports-first-quarter-fiscal-2026-financial-results/
[2] https://www.ainvest.com/news/medtronic-reports-q1-2025-earnings-sales-reach-8-578bn-net-income-1-04bn-2508/